Please see enclosed pdf.
Attachment
| Source: Coloplast A/S
Please see enclosed pdf.
Attachment
1 October 2025 - 30 September 2026 Coloplast delivered 5% organic growth in Q4, driven by continued strength in Chronic Care and Interventional Urology. EBIT growth1 in constant currencies was 0% and...
Read MoreAnnouncement no. 10/2026Inside information Revised financial ambition towards 2030 includes 5-7% organic growth per year and an EBIT margin1 in constant currencies in the mid-20% range over the...
Read More